Challenges focus on failure-to-warn ban. Tresa Baldas/Staff reporter – The National Law Journal Nearly one year after the U.S. Food and Drug Administration issued a
April 2007 Big Pharma Litigation Update – Drugs (Part II)
By Evelyn Pringle LawyersandSettlements.com Washington, DC: The anti-epileptic drug, Depakote (valproate), marketed by Abbott Laboratories, is one of the most heavily prescribed medications for off-label
Patients Diagnosed Schizophrenic and Bipolar To Boost Seroquel Sales
By Evelyn Pringle LawyersandSettlements.com Washington, DC: For over a decade, drug makers have been influencing doctors to diagnose patients, especially those covered by public health
Suicide Warning For Antidepressants Should Be Raised To Include Young Adults, FDA Panel Says
Stephen Spotswood U.S. Medicine January, 2007 Silver Spring, Md.-The Food and Drug Administration (FDA) is considering changing the black box warning labels already present on
Parties Debate Weight Of FDA Preemption Rule In Zoloft Federal Case
CAMDEN, N.J. – The significance of the Food and Drug Administration’s preamble to its Final Rule on prescription drug labeling was a central theme of
